Docoh
Loading...

COCP Cocrystal Pharma

Employees

Data from SEC filings
Employee count
CEO pay ratio
CEO Salary
Median Employee Salary

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On June 16, 2021, the 2021 Annual Meeting of Stockholders (the “2021 Annual Meeting”) of Cocrystal Pharma, Inc. (the “Company”) was held. At the 2021 Annual Meeting, the Company’s stockholders voted on (i) the election of five members of the Company’s Board of Directors for a one-year term expiring at the next annual meeting of stockholders (Proposal 1); (ii) ratification of the appointment of Weinberg & Company as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 (Proposal 2); (iii) approval of an amendment to the Certificate of Incorporation of the Company to increase the number of shares of common stock the Company is authorized to issue from 100,000,000 shares to 150,000,000 shares; (iv) approval of an amendment to the Cocrystal Pharma, Inc. 2015 Equity Incentive Plan (the “2015 Plan”) to increase the number of shares of common stock authorized for issuance under the 2015 Plan from 5,000,000 to 10,000,000 shares; (v) approval on a non-binding advisory basis of the compensation of the Company’s named executive officers; (vi) approval on a non-binding advisory basis the frequency with which the stockholders shall vote to approve executive compensation; and (vii) approval of an adjournment of the 2021 Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the 2021 Annual Meeting, all as described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 26, 2021.

Set forth below are the voting results on each matter submitted to the stockholders at the 2021 Annual Meeting.

Proposal 1. The Company’s stockholders voted to elect the following five individuals as directors to hold office until the next annual meeting of stockholders:

NomineeVotes ForVotes WithheldBroker Non-Votes
Dr. Phillip Frost18,940,43115,127,41314,538,824
Mr. Roger Kornberg19,900,49114,167,35314,538,824
Mr. Steven Rubin28,022,8176,045,02714,538,824
Dr. Anthony Japour28,248,6495,819,19514,538,824
Mr. Richard C. Pfenniger, Jr.19,751,28914,316,55514,538,824


Proposal 2. The Company’s stockholders voted to ratify the appointment of Weinberg & Company as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020.

Votes ForVotes AgainstAbstentions
38,767,5399,330,117509,012


Proposal 3. The Company’s stockholders voted to approve an amendment to the Certificate of Incorporation of the Company to increase the number of shares of common stock the Company is authorized to issue from 100,000,000 shares to 150,000,000 shares.

Votes ForVotes AgainstAbstentions
39,746,1138,574,793285,762






Proposal 4. The Company’s stockholders voted to approve an amendment to the 2015 Plan to increase the number of shares of common stock authorized for issuance under the 2015 Plan from 5,000,000 to 10,000,000 shares.

Votes ForVotes AgainstAbstentionsBroker Non-Votes
23,413,98410,315,529338,33114,538,824


Proposal 5. The Company’s stockholders voted to approve on a non-binding advisory basis of the compensation of the Company’s named executive officers.

Votes ForVotes AgainstAbstentionsBroker Non-Votes
21,405,13712,110,685552,02214,538,824


Proposal 6. The Company’s stockholders voted to approve on a non-binding advisory basis the frequency with which the stockholders shall vote to approve executive compensation.

Votes For One YearVotes For Two YearsVotes For Three YearsAbstentions
13,425,5531,051,42810,703,1798,887,684


As there were sufficient votes to approve proposals 1 through 6, proposal 7 was moot.